# REVUFORJ
> **NDA218944** · New Drug Application · Sponsor: SYNDAX · Approved 2024-11-15
## Drug
- **FDA Application Number:** NDA218944
- **Application type:** New Drug Application
- **Brand name:** REVUFORJ
- **Generic name:** REVUMENIB
- **Active ingredients:** REVUMENIB CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SYNDAX
- **Manufacturer:** Syndax Pharmaceuticals, Inc.
- **First approval:** 2024-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218944)
---
*MORVS · CC0 1.0*